Huakang Biomedical Holdings Company Limited (8622.HK) HKSE
0.33
+0.005(+1.54%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.33
+0.005(+1.54%)
Currency In HKD
Address
Effectual Building
Wan Chai,
Hong Kong
Phone
852 2202 8988
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
91
First IPO Date
December 13, 2018
| Name | Title | Pay | Year Born |
| Chunguang Zhang | Chief Executive Officer & Executive Director | 827,706 | 1968 |
| Xunyong Zhou | Co-Chairman | 46,048 | 1976 |
| Yujing Zhang | Co-Chairman | 46,048 | 1985 |
| Lai Yin Poon | Chief Financial Officer, Compliance Officer & Executive Director | 909,441 | 1972 |
| Lai Ki Chau | Financial Controller & Company Secretary | 0 | 1984 |
Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of in-vitro diagnostic (IVD) reagents in the People's Republic of China. It offers male and female fertility IVD, parasite antibody detection, and Epstein-Barr virus antibody detection reagents; auxiliary reproductive supplies and equipment; and healthcare products and supplements under the Nutronic brand to customers, as well as through online and offline platforms and channels. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992 and is headquartered in Wan Chai, Hong Kong.